1. Home
  2. PXED vs AMPH Comparison

PXED vs AMPH Comparison

Compare PXED & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PXED

Phoenix Education Partners Inc.

N/A

Current Price

$30.53

Market Cap

1.1B

Sector

Real Estate

ML Signal

N/A

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.26

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXED
AMPH
Founded
1976
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2025
2014

Fundamental Metrics

Financial Performance
Metric
PXED
AMPH
Price
$30.53
$26.26
Analyst Decision
Buy
Buy
Analyst Count
7
6
Target Price
$44.29
$31.00
AVG Volume (30 Days)
124.9K
322.7K
Earning Date
01-13-2026
02-26-2026
Dividend Yield
2.75%
N/A
EPS Growth
N/A
N/A
EPS
2.68
2.27
Revenue
$1,014,527,000.00
$723,305,000.00
Revenue This Year
$4.45
$1.37
Revenue Next Year
$4.75
$4.84
P/E Ratio
$11.39
$11.57
Revenue Growth
21.46
N/A
52 Week Low
$23.52
$20.39
52 Week High
$47.08
$37.66

Technical Indicators

Market Signals
Indicator
PXED
AMPH
Relative Strength Index (RSI) 46.46 46.67
Support Level $29.32 $25.63
Resistance Level $33.05 $26.71
Average True Range (ATR) 2.17 1.10
MACD 0.05 -0.16
Stochastic Oscillator 40.35 21.22

Price Performance

Historical Comparison
PXED
AMPH

About PXED Phoenix Education Partners Inc.

Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: